Travis Carbonneau, Director, Clinical Technology and Training at CereVasc and Danielle Kolesnik, Market Development Manager for NE will discuss the disease state of Normal Pressure Hydrocephalus (NPH), the treatment, STRIDE clinical trial, and a new technology approach through an Endovascular eShunt.  Click here to watch a recording of the presentation with passcode: yjqay4Y=